In a significant public health initiative, the ban on 16 fixed-dose drug combinations, including various antibiotics and topical formulatio...

As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...

A new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...

There are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...

The Delhi High Court has asked the Central Drugs Standard Control Organisation to review a petition challenging Zydus Lifesciences' approva...

Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

Bio Medica Laboratories' initial public offering begins subscription on Thursday. The company plans to raise Rs 52.43 crore through its IPO...

Roche Pharma India introduces a new injectable immunotherapy for lung cancer. This treatment takes only seven minutes, a significant reduct...

India’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...

Women are learning to keep pace with the ubiquitous apps and AI, shrugging off dependence on their kids for financial transactions, online ...

While banana peels are rich in nutrients, simply soaking them in water for plant fertilizer is largely ineffective. Research indicates that...

Global events like the West Asia conflict and El Nino threaten governments. Rising fertilizer prices create a fiscal and political crisis f...

The ban is effective immediately and may shave off over Rs 1,500 crore from India’s Rs 1.18 lakh crore pharmaceutical industry

A Central government notification banning 344 such fixed-dose combinations in 2016 was set aside by the Delhi High Court in December.

India's drug pricing watchdog National Pharmaceutical Pricing Authority (NPPA) has moved in to back the health ministry.

The Kerala HC has granted the state chemist and druggist association an extension to return the brands banned by a recent government order ...

At least four drugmakers have rushed to court following the ban on more than 300 fixed-dose combination (FDC) medicines.